-
-
Call more information
660-596-2224 -
AUTHORS: Slupe, Andrew M. MD, PhD et al Anesthesia & Analgesia: December 2019 – Volume 129 – Issue 6 – p 1529-1535 BACKGROUND: Dexmedetomidine (Dex) is an attractive agent for procedural sedation due to its unique pharmacodynamic profile, specifically affording predictable sedation without concurrent respiratory depression. However, Dex has previously been reported to prevent or […]
Read MoreAUTHORS: Shin, Hyun-Jung MD, PhD et al Anesthesia & Analgesia: December 2019 – Volume 129 – Issue 6 – p 1512-1518 BACKGROUND: In patients undergoing total knee arthroplasty under spinal anesthesia, we compared the postoperative analgesic effect of intraoperative sedation with dexmedetomidine versus propofol. We hypothesized that sedation with dexmedetomidine would result in lower postoperative […]
Read MoreBy Kelly Young Gabapentin and pregabalin may cause serious breathing problems in patients who have respiratory risk factors, such as using opioids or other central nervous system depressants, having an underlying respiratory condition like chronic obstructive pulmonary disease, or being elderly, according to a safety update from the FDA. The agency notes that use and […]
Read MoreAUTHORS: Arnolds, David E. MD, PhD et al Anesthesia & Analgesia: December 2019 – Volume 129 – Issue 6 – p 1621-1626 BACKGROUND: Many cases of maternal mortality and morbidity are preventable. A delayed response to clinical warning signs contributes to preventability. Therefore, the National Partnership for Maternal Safety devised maternal early warning criteria (MEWC), composed […]
Read MoreI wanted to share so our readers or their family and friends that need this undergo this test. By Amy Orciari Herman Just one in eight U.S. adults who meet U.S. Preventive Services Task Force (USPSTF) criteria for lung cancer screening actually receive it, according to findings in MMWR. In 2013, the USPSTF recommended annual screening […]
Read More